共 8 条
- [2] Responding to FDA-483s and warning letters BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (10): : 26 - 29
- [8] A Retrospective Analysis of Clinical Research Misconduct Using FDA-Issued Warning Letters and Clinical Investigator Inspection List From 2010 to 2014 ANESTHESIA AND ANALGESIA, 2018, 126 (03): : 976 - 982